5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.63▲ | 4.59▲ | 4.57▲ | 4.67▲ | 4.43▲ |
MA10 | 4.57▲ | 4.54▲ | 4.63▲ | 4.66▲ | 4.30▲ |
MA20 | 4.56▲ | 4.64▲ | 4.70▲ | 4.42▲ | 3.69▲ |
MA50 | 4.54▲ | 4.67▲ | 4.59▲ | 4.29▲ | 5.50▼ |
MA100 | 4.61▲ | 4.60▲ | 4.61▲ | 3.69▲ | N/A |
MA200 | 4.69▲ | 4.56▲ | 4.40▲ | 4.73▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.017▲ | 0.004▲ | -0.019▼ | 0.011▲ | 0.315▲ |
RSI | 67.774▲ | 55.336▲ | 53.216▲ | 57.712▲ | 52.001▲ |
STOCH | 89.639▲ | 66.108 | 32.051 | 53.177 | 74.299 |
WILL %R | -7.143▲ | -33.333 | -44.615 | -32.971 | -12.908▲ |
CCI | 152.946▲ | 82.862 | -6.112 | 25.454 | 95.493 |
Thursday, August 14, 2025 04:40 AM
Breakthrough Therapy designation granted for LX2006 based on interim data from Phase I/II trials demonstrating clinically meaningful improvements in cardiac and neurologic measures of Friedreich ...
|
Wednesday, July 30, 2025 05:00 PM
Fintel reports that on July 31, 2025, Oppenheimer initiated coverage of Lexeo Therapeutics (NasdaqGM:LXEO) with a Outperform recommendation. Analyst Price Forecast Suggests 309.73% Upside As of ...
|
Tuesday, July 29, 2025 07:27 AM
Lexeo Therapeutics, Inc. (NASDAQ:LXEO) is one of the 11 Best New Penny Stocks to Buy Right Now. On July 7, Stifel reiterated its “Buy” rating for Lexeo Therapeutics, Inc. (NASDAQ:LXEO) with a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 4.91 | 4.945 | 4.3273 | 4.72 | 663,551 |
14/08/25 | 4.71 | 4.99 | 4.56 | 4.79 | 377,276 |
13/08/25 | 4.70 | 4.9653 | 4.57 | 4.72 | 265,968 |
12/08/25 | 4.52 | 4.67 | 4.39 | 4.67 | 145,581 |
11/08/25 | 4.37 | 4.63 | 4.3418 | 4.44 | 212,390 |
08/08/25 | 4.45 | 4.54 | 4.35 | 4.53 | 190,783 |
07/08/25 | 4.76 | 4.78 | 4.42 | 4.45 | 206,204 |
06/08/25 | 4.74 | 4.81 | 4.50 | 4.76 | 194,934 |
05/08/25 | 4.76 | 4.81 | 4.6117 | 4.73 | 174,559 |
04/08/25 | 4.62 | 4.96 | 4.4922 | 4.77 | 241,754 |
|
|
||||
|
|
||||
|
|